- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/07 - Tetrapeptides
Patent holdings for IPC class A61K 38/07
Total number of patents in this class: 1639
10-year publication summary
|
167
|
124
|
154
|
149
|
175
|
134
|
184
|
142
|
118
|
36
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Stealth Biotherapeutics Inc. | 143 |
74 |
| CARA Therapeutics, Inc. | 73 |
36 |
| Cornell Research Foundation, Inc. | 389 |
23 |
| The Regents of the University of California | 18943 |
19 |
| Cornell University | 3036 |
17 |
| Onyx Therapeutics, Inc. | 71 |
17 |
| Biotempt B.V. | 28 |
15 |
| ISP Investments Inc. | 485 |
15 |
| Amgen Inc. | 3779 |
14 |
| Northwestern University | 3112 |
14 |
| Mondobiotech Laboratories AG | 311 |
14 |
| Stealth Biotherapeutics Corp | 36 |
14 |
| Stealth Peptides International, Inc. | 31 |
14 |
| Cytogel Pharma, LLC | 23 |
13 |
| The Feinstein Institute for Medical Research | 243 |
13 |
| S.i.s. Shulov Innovative Science Ltd. | 14 |
12 |
| Agency for Science, Technology and Research | 3512 |
11 |
| Jiangsu Hengrui Medicine Co., Ltd. | 780 |
11 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 588 |
11 |
| Purdue Research Foundation | 3277 |
10 |
| Other owners | 1272 |